Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verwaal, V. J.
Right arrow Articles by Zoetmulder, F. A.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verwaal, V. J.
Right arrow Articles by Zoetmulder, F. A.N.
Related Articles
Right arrowRelated Correspondence
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 20 (October), 2003: 3737-3743
© 2003 American Society for Clinical Oncology

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, Frans A.N. Zoetmulder

From the Departments of Surgery, Biometrics, and Gastroenterology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

Address reprint requests to Vic J. Verwaal, MD, Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; e-mail: v.verwaal{at}nki.nl.

Purpose: To confirm the findings from uncontrolled studies that aggressive cytoreduction in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) is superior to standard treatment in patients with peritoneal carcinomatosis of colorectal cancer origin.

Patients and Methods: Between February 1998 and August 2001, 105 patients were randomly assigned to receive either standard treatment consisting of systemic chemotherapy (fluorouracil-leucovorin) with or without palliative surgery, or experimental therapy consisting of aggressive cytoreduction with HIPEC, followed by the same systemic chemotherapy regime. The primary end point was survival.

Results: After a median follow-up period of 21.6 months, the median survival was 12.6 months in the standard therapy arm and 22.3 months in the experimental therapy arm (log-rank test, P = .032). The treatment-related mortality in the aggressive therapy group was 8%. Most complications from HIPEC were related to bowel leakage. Subgroup analysis of the HIPEC group showed that patients with 0 to 5 of the 7 regions of the abdominal cavity involved by tumor at the time of the cytoreduction had a significantly better survival than patients with 6 or 7 affected regions (log-rank test, P < .0001). If the cytoreduction was macroscopically complete (R-1), the median survival was also significantly better than in patients with limited (R-2a), or extensive residual disease (R-2b; log-rank test, P < .0001).

Conclusion: Cytoreduction followed by HIPEC improves survival in patients with peritoneal carcinomatosis of colorectal origin. However, patients with involvement of six or more regions of the abdominal cavity, or grossly incomplete cytoreduction, had still a grave prognosis.

Supported with grant OG98-041 from Ontwikkelings Geneeskunde.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Correspondence

  • Intraperitoneal Hyperthermic Chemotherapy As Treatment of Peritoneal Carcinomatosis of Colorectal Cancer
    Maurie Markman
    JCO 2004 22: 1527 [Full Text]
  • Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinosis
    Bert Hildebrandt, Beate Rau, Johanna Gellermann, Peter Wust, and Hanno Riess
    JCO 2004 22: 1527-1529 [Full Text]

Related Reply

  • In Reply:
    Vic J. Verwaal
    JCO 2004 22: 1529 [Full Text]


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
D. C. Gammon, T. Dutton, B. Piperdi, J. Zybert, S. H. Wolfe, E. Nguyen, D. Sbat, V. G. Pillarisetty, M. Sullivan, and G. F. Whalen
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1186 - 1190.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
M. VAIRA, T. CIOPPA, G. DE MARCO, C. BING, S. D'AMICO, M. D'ALESSANDRO, G. FIORENTINI, and M. DE SIMONE
Management of Pseudomyxoma Peritonei by Cytoreduction+HIPEC (Hyperthermic Intraperitoneal Chemotherapy): Results Analysis of a Twelve-year Experience
In Vivo, July 1, 2009; 23(4): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
F. CAVALIERE, D. GIANNARELLI, M. VALLE, O. FEDERICI, G. LIOTTA, P. PERRI, F. DI FILIPPO, A. GAROFALO, and P. IALONGO
Peritoneal Carcinomatosis from Ovarian Epithelial Primary: Combined Aggressive Treatment
In Vivo, May 1, 2009; 23(3): 441 - 446.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Elias, J. H. Lefevre, J. Chevalier, A. Brouquet, F. Marchal, J.-M. Classe, G. Ferron, J.-M. Guilloit, P. Meeus, D. Goere, et al.
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
J. Clin. Oncol., February 10, 2009; 27(5): 681 - 685.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
E. A. Levine, B. M. Ronnett, P. F. Mansfield, and C. Eng
Overview of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Dissemination of Appendiceal and Colorectal Neoplasms
ASCO Educational Book, January 1, 2008; 2008(1): 153 - 159.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
L. Bijelic, A. Jonson, and P. H. Sugarbaker
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
Ann. Onc., December 1, 2007; 18(12): 1943 - 1950.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T. Yan, L Welch, D Black, and P. Sugarbaker
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
Ann. Onc., May 1, 2007; 18(5): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Morgan Jr., T. W. Synold, B. Xi, D. Lim, S. Shibata, K. Margolin, R. E. Schwarz, L. Leong, G. Somlo, P. Twardowski, et al.
Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Clin. Cancer Res., February 15, 2007; 13(4): 1232 - 1237.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Links
Analogies between reading of medical and religious texts
BMJ, November 18, 2006; 333(7577): 1068 - 1070.
[Full Text] [PDF]


Home page
JNMHome page
M. J. Koppe, T. Hendriks, O. C. Boerman, W. J.G. Oyen, and R. P. Bleichrodt
Radioimmunotherapy Is an Effective Adjuvant Treatment After Cytoreductive Surgery of Experimental Colonic Peritoneal Carcinomatosis
J. Nucl. Med., November 1, 2006; 47(11): 1867 - 1874.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. D. Yan, D. Black, R. Savady, and P. H. Sugarbaker
Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma
J. Clin. Oncol., August 20, 2006; 24(24): 4011 - 4019.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
P. H Sugarbaker, O. A. Stuart, and D. Yoo
Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy
Journal of Oncology Pharmacy Practice, September 1, 2005; 11(3): 111 - 119.
[Abstract] [PDF]


Home page
The OncologistHome page
P. H. Sugarbaker, J. T. Mora, P. Carmignani, O. A. Stuart, and D. Yoo
Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy
Oncologist, February 1, 2005; 10(2): 112 - 122.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Elias, T. Matsuhisa, L. Sideris, G. Liberale, L. Drouard-Troalen, B. Raynard, M. Pocard, J. M. Puizillou, V. Billard, P. Bourget, et al.
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance
Ann. Onc., October 1, 2004; 15(10): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M. De Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, et al.
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
J. Clin. Oncol., August 15, 2004; 22(16): 3284 - 3292.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. Chau, A. R. Norman, D. Cunningham, J. S. Waters, J. Oates, and P. J. Ross
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer--Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
J. Clin. Oncol., June 15, 2004; 22(12): 2395 - 2403.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Elias, L. Sideris, M. Pocard, C. Ede, D. Ben Hassouna, M. Ducreux, V. Boige, J. F. Cote, and P. Lasser
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients
Ann. Onc., May 1, 2004; 15(5): 781 - 785.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Markman
Intraperitoneal Hyperthermic Chemotherapy As Treatment of Peritoneal Carcinomatosis of Colorectal Cancer
J. Clin. Oncol., April 15, 2004; 22(8): 1527 - 1527.
[Full Text] [PDF]


Home page
JCOHome page
B. Hildebrandt, B. Rau, J. Gellermann, P. Wust, and H. Riess
Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinosis
J. Clin. Oncol., April 15, 2004; 22(8): 1527 - 1529.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online